KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) FCF Margin: 2018-2025

Historic FCF Margin for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to -24.48%.

  • Twist Bioscience's FCF Margin fell 404.00% to -24.48% in Q3 2025 from the same period last year, while for Sep 2025 it was -20.08%, marking a year-over-year increase of 202.00%. This contributed to the annual value of -20.08% for FY2025, which is 202.00% up from last year.
  • Latest data reveals that Twist Bioscience reported FCF Margin of -24.48% as of Q3 2025, which was down 122.61% from -11.00% recorded in Q2 2025.
  • In the past 5 years, Twist Bioscience's FCF Margin ranged from a high of -9.01% in Q2 2024 and a low of -154.40% during Q1 2022.
  • Its 3-year average for FCF Margin is -30.72%, with a median of -26.59% in 2024.
  • Its FCF Margin has fluctuated over the past 5 years, first spiked by 21,263bps in 2021, then slumped by 4,881bps in 2022.
  • Twist Bioscience's FCF Margin (Quarterly) stood at -141.45% in 2021, then spiked by 1,997bps to -121.48% in 2022, then surged by 8,724bps to -34.24% in 2023, then soared by 753bps to -26.71% in 2024, then plummeted by 404bps to -24.48% in 2025.
  • Its FCF Margin stands at -24.48% for Q3 2025, versus -11.00% for Q2 2025 and -18.46% for Q1 2025.